PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
Connie Celum(University of Washington), Sinéad Delany‐Moretlwe(University of Cape Town), Mandisa Tsholwana(University of the Witwatersrand), Adeola Adeyeye(National Institutes of Health), Sybil Hosek(University of Illinois Chicago), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Bonnie J. Dye(Family Health International 360), Yaw Agyei, James F. Rooney(Gilead Sciences (United States)), Lubbe Wiesner(Jisc), Ethan Wilson(Fred Hutch Cancer Center), Peter L. Anderson(University of Colorado Denver), Shorai Mukaka(University of Zimbabwe), Subash Pathak(Fred Hutch Cancer Center), Heather Noble, Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Scott M. Rose(Family Health International 360), Sheetal Kassim(Desmond Tutu HIV Foundation), Nyaradzo Mgodi(University of Zimbabwe), Krista Yuha(Fred Hutch Cancer Center), Jessica M. Fogel(Johns Hopkins University)
Cited by 181
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817